Key result
The combination of low free triiodothyronine (FT3 < 2.77 pg/mL) and the presence of late gadolinium enhancement strongly predicted mortality in patients with idiopathic dilated cardiomyopathy (HR 8.623).
Why the study?
Does free triiodothyronine (FT3) level correlate with myocardial injury and prognosis in patients with idiopathic dilated cardiomyopathy?
Observational (n=71)
No
Does free triiodothyronine (FT3) level correlate with myocardial injury and prognosis in patients with idiopathic dilated cardiomyopathy?
Hazard Ratio: 8.623 (95% CI 3.626–16.438)
p-value: p=0.001
Low FT3 levels correlate with myocardial fibrosis and perfusion/metabolism abnormalities, and combined with LGE, strongly predict adverse cardiac events in idiopathic dilated cardiomyopathy.
May aid risk stratification in idiopathic dilated cardiomyopathy; hypothesis-generating and requires prospective validation before clinical use.
Thyroid dysfunction is associated with poor prognosis in heart failure, but theories of mechanisms are mainly based on animal experiments, not on human level. We aimed to explore the relation between thyroid function and myocardial injuries in idiopathic dilated cardiomyopathy (IDCM) using cardiac magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Myocardial fibrosis was detected by late gadolinium enhancement (LGE) MRI, and myocardial perfusion/metabolism was evaluated by 99m Tc-MIBI SPECT / 18 F-FDG PET imaging. Across the quartiles of FT3, decreased percentage of segments with LGE and perfusion/metabolism abnormalities were found. As for FT4 and TSH levels, no significant distribution trend of myocardial injuries could be detected. In logistic analysis, FT3 was independently associated with the presence of LGE (OR: 0.140, 95% CI: 0.035–0.567), perfusion abnormalities (OR: 0.172, 95% CI: 0.040–0.738) and metabolism abnormalities (OR: 0.281, 95% CI: 0.081–0.971). After a median follow-up of 46 months, LGE-positive and FT3 < 2.77 pg/mL was identified as the strongest predictor of cardiac events (HR: 8.623, 95% CI: 3.626–16.438). Low FT3 level is associated with myocardial fibrosis and perfusion/metabolism abnormalities in patients with IDCM. The combination of FT3 level and LGE provides useful information for assessing the prognosis of IDCM.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) conducted an observational in Idiopathic Dilated Cardiomyopathy (IDCM) (n=71). Low Free Triiodothyronine (FT3 < 2.77 pg/mL) and presence of Late Gadolinium Enhancement (LGE) vs. FT3 ≥ 2.77 pg/mL and absence of LGE was evaluated on All-cause mortality (or cardiac events) (HR 8.623, 95% CI 3.626-16.438, p=0.001). The combination of low free triiodothyronine (FT3 < 2.77 pg/mL) and the presence of late gadolinium enhancement strongly predicted mortality in patients with idiopathic dilated cardiomyopathy (HR 8.623).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: